Geron Corp

Ownership Transactions Reported by 21 Insiders

Symbol
GERN on Nasdaq, GERNW on OTC
Industry
Pharmaceutical Preparations
Location
919 East Hillsdale Boulevard, Suite 250, Foster City, CA

Insiders trading volume in the past year

Geron Corp executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
John A. Scarlett Chairman, President and CEO, Director $2.11M +$22.1K +1.06% Feb 27, 2025
Andrew J. Grethlein EVP, Chief Operating Officer $638K Feb 18, 2025
James Ziegler EVP, Chief Commercial Officer $566K +$160K +39.5% Feb 27, 2025
Scott A. Samuels EVP, Chief Legal Officer $517K +$24.2K +4.9% Feb 27, 2025
Michelle Robertson EVP, Chief Financial Officer $501K Feb 18, 2025
Robert J. Spiegel Director $258K Sep 30, 2025
Karin Eastham Director $249K Jan 13, 2023
Olivia Kyusuk Bloom EVP, Chief Financial Officer $170K Aug 15, 2023
V. Bryan Lawlis Director $15.7K +$15.7K May 21, 2025
Ahmed ElNawawi EVP, Chief Commercial Officer $13.7K Oct 20, 2025
Anil Kapur EVP, Corp Strategy & CCO $0 Jun 10, 2024
Faye Feller EVP, Chief Medical Officer $0 Jun 10, 2024
Gaurav Aggarwal Director May 21, 2025
Stephen Rosenfield EVP, Chief Legal Off & Sec Feb 16, 2022
Elizabeth G. O'Farrell Director May 21, 2025
John F. McDonald Director May 21, 2025
Susan Molineaux Director May 21, 2025
Harout Semerjian President and CEO, Director Aug 7, 2025
Joseph Eid EVP, Research and Development Nov 11, 2024
Aleksandra Rizo EVP, Chief Medical Officer Feb 16, 2022
Dawn Carter Bir Interim President and CEO, Director May 21, 2025

Recent Insider Transactions by Companies or Individuals for Geron Corp

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.